KS-16

N/A

Report date: 2025/06/11 10:31:07
NME

Base Information

Drug NameKS-16
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionAnticancer protein kinase inhibitorsSerine/threonine-protein kinase B-raf inhibitors
TargetsSerine/threonine-protein kinase B-raf
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEgyptUnited KingdomSouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKorea Institute Of Science And Technology
China Registration ClassN/A

Develop Information

Active CompaniesNapier University of EdinburghNational Research Centre of EgyptKorea Institute Of Science And Technology +[5] 
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A